Microplasmin

DRUG8 trials

Sponsors

ThromboGenics, University of California, Los Angeles, National Institutes of Health Clinical Center (CC)

Conditions

Arterial Occlusive DiseasesDeep Vein ThrombosisEye DiseasesFocal Vitreomacular AdhesionMacular DegenerationStrokeStroke, AcuteUveitis

Phase 1

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

TerminatedNCT01194674

National Institutes of Health Clinical Center (CC)Uveitis

Start: 2011-01-31End: 2011-12-31Updated: 2018-07-31

Phase 2

Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

CompletedNCT00123279

ThromboGenicsEye Diseases, Vitreomacular Traction Maculopathy

Start: 2004-12-31End: 2008-11-30Updated: 2014-04-07

Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion

TerminatedNCT00123266

ThromboGenicsStroke

Start: 2006-12-31End: 2008-08-31Updated: 2014-04-07

Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

CompletedNCT00123305

ThromboGenicsStroke, Acute

Start: 2005-10-31End: 2008-06-30Updated: 2014-11-07

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

TerminatedNCT00123292

ThromboGenicsArterial Occlusive Diseases

Start: 2005-03-31End: 2009-11-30Updated: 2014-04-07

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

TerminatedNCT00428129

ThromboGenicsDeep Vein Thrombosis

Start: 2007-03-31End: 2008-10-31Updated: 2014-04-07

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

University of California, Los AngelesMacular Degeneration

Start: 2009-10-31End: 2011-12-31Target: 30Updated: 2011-09-27

Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion

CompletedNCT01055535

ThromboGenicsFocal Vitreomacular Adhesion

Start: 2010-01-31End: 2011-04-30Updated: 2014-04-07